Dr. David Whiteman, MD – Cambridge, MA

Clinical Biochemical Genetics, Clinical Biochemical/Molecular Genetics, Clinical Cytogenetics, Clinical Genetics

VP, Research & Development, Global Program Leader, Rare Metabolic Diseases, Takeda Pharmaceuticals